McBride Full-Year Results 2026: Profits Fall, but Eurotab and Vestacy Transform the Growth Outlook

McBride's results at a glance

McBride PLC has delivered resilient sales for the year ended 30 June 2026, although higher input and logistics costs squeezed margins during the final quarter.

The more important part of the investment story may sit outside the reported numbers. The post-year-end acquisition of Eurotab and a major manufacturing partnership with Vestacy could materially increase McBride's scale, revenue and earnings over the next two years.

Key figure	2026	2025	Change
Revenue	£934.2 million	£926.5 million	+0.8%
Adjusted operating profit	£59.0 million	£66.1 million	-£7.1 million
Adjusted EBITDA	£80.0 million	£85.8 million	-£5.8 million
Adjusted EBITDA margin	8.6%	9.3%	-0.7 percentage points
Adjusted profit before tax	£48.8 million	£54.9 million	-£6.1 million
Adjusted basic EPS	21.6p	22.1p	-0.5p
Net debt	£122.8 million	£105.2 million	+£17.6 million
Proposed dividend per share	3.1p	3.0p	+0.1p

Investors can read the original company announcement for the complete preliminary results.

Stable revenue did not translate into stable profits

Revenue increased by 0.8% to £934.2 million, although it fell by 1.8% on a constant-currency basis. Constant currency removes the effect of exchange-rate movements, giving investors a clearer view of underlying trading.

Private label volumes grew by 0.4%, helping to offset weaker contract manufacturing and McBride-branded demand. This suggests the company's value-focused products remain relevant as households face renewed inflationary pressure.

However, adjusted operating profit fell from £66.1 million to £59.0 million. Adjusted EBITDA, meaning earnings before interest, tax, depreciation and amortisation with certain items excluded, declined from £85.8 million to £80.0 million.

The adjusted EBITDA margin consequently dropped from 9.3% to 8.6%, moving McBride further away from its 10% ambition in the reported year.

Management primarily blamed significant fourth-quarter increases in petrochemical-derived materials, packaging, energy, haulage and other logistics costs following geopolitical disruption in the Middle East.

McBride estimates that adjusted operating profit would have been approximately £65 million without this impact. The problem was not simply the increase in costs, but the delay between those costs arriving and customer price increases taking effect.

The margin recovery remains a key uncertainty

McBride has agreed pricing changes with all customers and expects margins to recover during the second quarter of its 2027 financial year. That expectation remains dependent on movements in material prices.

This is important because further customer price increases are already described as increasingly likely. McBride operates a disciplined three-month pricing process, but any delay still creates a period in which the company absorbs higher costs.

Volumes during the first two months of the new year were in line with internal expectations. Management also noted possible early signs of stronger demand in some markets, potentially reflecting consumers switching towards better-value private label products.

That provides a supportive backdrop, but input costs remain difficult to forecast. Investors should therefore distinguish between management's expected margin recovery and a recovery that has already been delivered.

Cash flow weakened and net debt increased

Free cash flow fell to £56.7 million from £93.9 million, largely because working capital swung from a £13.7 million inflow to a £19.7 million outflow.

Net debt increased by £17.6 million to £122.8 million, taking net debt to 1.5 times adjusted EBITDA, compared with 1.2 times last year. Gearing also increased from 53.3% to 56.7%.

Part of the increase reflects McBride drawing €40 million from its revolving credit facility before year-end, ensuring funds were available to complete the Eurotab acquisition in July.

Liquidity stood at £167.6 million, with £100.6 million undrawn on the facility. McBride also remained comfortably within its banking requirements. The balance sheet does not appear immediately stretched based on the disclosed covenant figures, but debt is moving upwards as the company invests and returns capital to shareholders.

Shareholders received £18 million

McBride deployed £18.0 million towards shareholder returns during the year, compared with £2.4 million in 2025.

This included:

• £5.2 million of dividend payments
• £6.4 million spent through the share buyback programme
• £6.4 million used by the Employee Benefit Trust to purchase shares and reduce future dilution from incentive awards

The board has proposed a final dividend of 3.1p per share, up from 3.0p. Subject to shareholder approval, it will be paid on 27 November 2026 to investors on the register on 30 October 2026.

McBride repurchased 4,479,384 shares during the year at an average price of 142.6p. This represented 2.5% of the issued ordinary share capital at 30 June 2026.

These returns demonstrate confidence, although investors must balance them against higher debt, continued capital expenditure and the funding required for future growth projects.

Eurotab expands McBride's product range

McBride completed the Eurotab acquisition after the financial year ended, so its contribution is not included in the reported 2026 revenue or profit figures.

The business was acquired for an enterprise value of €35.6 million, equivalent to £30.7 million. Eurotab manufactures solid-format cleaning and hygiene products, including dishwasher tablets, moisture-absorbing products and disinfecting bleach tablets.

The latter two categories are new for McBride. Eurotab also brings manufacturing operations in France and near Istanbul, extending McBride's geographic reach and customer relationships.

Management expects the acquisition to increase earnings per share from completion, with further benefits available from identified synergies. The exact value and timing of those synergies were not disclosed.

Integration has reportedly started well, but delivery now matters. Acquisition benefits depend on retaining customers, controlling costs and successfully combining the operations.

Vestacy could add approximately £170 million of revenue

The Vestacy agreement is potentially the most significant feature of the announcement.

Under the multi-year partnership, McBride will manufacture household products for Vestacy across Europe, primarily in laundry. McBride is also acquiring dedicated manufacturing facilities in Spain and Portugal for nominal consideration.

Vestacy will fund new production equipment across McBride's European network, alongside targeted investment by McBride. This reduces the amount of capital McBride must supply itself.

Once fully operational in calendar 2028, the agreement is expected to add approximately £170 million of annual revenue at Group-average margins. Management says the partnership should increase Group revenue and earnings by 15% at maturity.

This is a substantial opportunity relative to current annual revenue of £934.2 million. However, it is forward-looking and depends on site transitions, capital procurement, production ramp-up and successful execution over the coming years.

Transformation benefits provide another lever

McBride's internal Transformation programme delivered £15.3 million of cumulative net benefits during the year. The company remains on track for its £50 million target by June 2028.

The UK implementation of SAP S/4HANA, an enterprise resource planning system used to manage core business processes, went live in November 2025. Two large European sites are expected to follow during the new financial year.

These projects should support efficiency and control, but they also carry implementation risk. The 2026 results included £2.2 million of exceptional SAP-related disruption, integration and assurance costs.

What investors should watch in 2027

The reported results show a fundamentally profitable business whose near-term margins remain exposed to volatile input costs. The dividend, buyback and transformation savings are encouraging, but lower profits, weaker free cash flow and increased debt deserve attention.

The main indicators to monitor are:

• whether margins recover during the second quarter as expected
• the direction of raw material, packaging and logistics costs
• progress towards the £50 million transformation target
• Eurotab's first-year financial contribution and integration
• delivery of the Vestacy production transition
• whether net debt remains controlled as investment continues

McBride's existing business has produced a resilient rather than spectacular year. The investment case now rests increasingly on whether management can convert Eurotab and Vestacy from attractive strategic announcements into profitable, cash-generative growth.